85-5569-10　(-)-Eseroline Fumarate Salt 1mg　CAS No:70310-73-5,Parent compound: 469-22-7　448449

特徴

• (-)-Eseroline Fumarate Salt is a metabolite of physostigmine, displaying both anti-acetylcholinesterase and opiate agonist activities.
• Synonyms:(3aR,8bS)-3,4,8b-Trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol Fumarate; Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, (3aS,8aR)-, (2E)-2-butenedioate (1:1) (salt) (9CI); Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, (3aS-cis)-, (E)-2-butenedioate (1:1) (salt); Pyrrolo[2, 3- b] indol- 5- ol, 1, 2, 3, 3a, 8, 8a- hexahydro- 1, 3a, 8- trimethyl-, (3aS, 8aR) -, (2E) - 2- butenedioate (1:1); (-)-Eseroline fumarate; Eseroline fumarate
• Molecular Formula:C₁₃H₁₈N₂O•( C₄H₄O₄)
• Molecular Weight:334.37
• Specific Rotation (c=0.5, methanol):-115.0- -100º
• Solubility:0.1M HCl; 0.1M NaOH; H2OMethanol: slightly soluble(All solutions should be freshly prepared.)
• Storage and Stability:Store at 4°C. Stable for 6 months after receipt at 4°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
• Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
• Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.